Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Tryptophanyl-tRNA synthetase (WRS) is essential for protein synthesis via aminoacylation.
• WRS is increasingly recognized for its involvement in various human diseases.
• Its potential as a pharmacological target is under active investigation.

Purpose of the Study:

• To review the diverse roles of WRS in human diseases.
• To consolidate current understanding of WRS's physiopathological involvement.
• To underscore WRS as a potential therapeutic target for drug development.

Main Methods:

• Literature review of studies on WRS and disease.
• Analysis of WRS's involvement in infection, cancer, and autoimmune/brain diseases.
• Synthesis of information on WRS's pharmacological potential.

Main Results:

• WRS plays critical roles beyond translation in pathological conditions.
• Evidence links WRS to sepsis, cancer, autoimmune disorders, and brain diseases.
• The enzyme's non-canonical functions are key to its disease relevance.

Conclusions:

• WRS is implicated in a spectrum of human diseases, including infection, tumorigenesis, and neurological conditions.
• Further research into WRS mechanisms and therapeutic targeting is warranted.
• WRS represents a promising target for novel drug development in multiple pathological states.